Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung CancerYoshimasa Shiraishi, Isamu Okamoto, Hirotaka Matsumoto et al.|JAMA Oncology|2023Cited by 52
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027Yuji Minegishi, Akihiko Gemma, Ou Yamaguchi et al.|BMC Cancer|2021Cited by 18
Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non–Small-Cell Lung CancerYoshimasa Shiraishi, Isamu Okamoto, Junji Kishimoto et al.|Clinical Lung Cancer|2020Cited by 15